SCHEMBL18979944

SCHEMBL18979944

O=c1c(Br)c(O)cnn1Cc1ccccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.63
▸ KMT2A Q03164 3/20 0.63
▸ SMN1; SMN2 Q16637 3/20 0.63
▸ RAB9A P51151 2/20 0.63
▸ NPSR1 Q6W5P4 2/20 0.63
▸ POLB P06746 1/20 0.63
▸ BLM P54132 1/20 0.63
▸ GPR35 Q9HC97 1/20 0.63
▸ LMNA P02545 3/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.45
▸ HPGD P15428 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ S1PR4 O95977 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.45
▸ XBP1 P17861 1/20 0.45
▸ S1PR1 P21453 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ TLR9 Q9NR96 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18980285 0.87 SMN1; SMN2 (0.73) MEN1KMT2ASMN1; SMN2RAB9ANPSR1
SCHEMBL18979949 0.86 RAB9A (0.67) MEN1KMT2ASMN1; SMN2RAB9ANPSR1
SCHEMBL6604659 0.82 PFKFB3 (0.52) SMN1; SMN2NPSR1LMNAALDH1A1HPGD
SCHEMBL18979972 0.80 POLB (0.59) MEN1KMT2ASMN1; SMN2RAB9ANPSR1
SCHEMBL18980164 0.80 RAB9A (0.76) MEN1KMT2ASMN1; SMN2RAB9ANPSR1
SCHEMBL10642561 0.78 RAB9A (1.00) MEN1KMT2ASMN1; SMN2RAB9ANPSR1
SCHEMBL17099741 0.75 MEN1 (0.73) MEN1KMT2ASMN1; SMN2RAB9ANPSR1
SCHEMBL18979930 0.74 NPSR1 (0.76) MEN1KMT2ASMN1; SMN2RAB9ANPSR1
SCHEMBL19000728 0.74 MEN1 (0.67) MEN1KMT2ASMN1; SMN2RAB9ANPSR1
SCHEMBL25465828 0.74 KMT2A (0.58) MEN1KMT2ASMN1; SMN2RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS BAK1, DCLRE1B, BLVRB MEN1 4584/4885KMT2A 4485/4885SMN1; SMN2 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback